Saúde Pública
Seguimento de longo prazo de estudo randomizado mostrou que bebês que receberam fórmula láctea enriquecida com suplementos ou nutrientes não apresentaram desempenho acadêmico melhor na adolescência.
17 Nov, 2021 | 12:43hComunicado de imprensa: Study finds no benefit of enriched formula milks on later academic performance – British Medical Journal
Editorial: Enriched formula milks and academic performance in later childhood – The BMJ
Comentário no Twitter
Children who are given nutrient or supplement enriched formula milk as babies do not appear to have higher exam scores as adolescents than those fed with standard formula, suggests a study published @bmj_latest today https://t.co/QmE2QxRlXm @DrMaxVerfuerden
— BMJ (@bmj_company) November 11, 2021
Novo relatório da OMS mapeia as barreiras à disponibilidade de insulina e sugere ações que promovam o acesso universal – “100 anos depois de sua descoberta, a insulina ainda está fora do alcance de muitos que vivem com diabetes.”
16 Nov, 2021 | 12:34hComunicado de imprensa: New WHO report maps barriers to insulin availability and suggests actions to promote universal access – World Health Organization
Relatório: Keeping the 100-year-old promise: making insulin access universal – World Health Organization
Comentário: Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows – Health Policy Watch
Conteúdos relacionados:
Editorial | Insulin for all: a hope yet to be realized.
One hundred years of insulin therapy.
Comentário no Twitter (fio – clique para saber mais)
The 🆕 WHO report on global access to #insulin shows how a century after its discovery, insulin remains inaccessible or unaffordable for many children and adults living with #diabetes around the 🌍🌎🌏.
More here 👉https://t.co/kcaqh6tYO1
— World Health Organization (WHO) (@WHO) November 12, 2021
Descarbonização da atenção à saúde em países de baixa e média rendas: potenciais caminhos para emissões zero.
16 Nov, 2021 | 12:18h
Comentário no Twitter
Healthcare in low and middle income countries has a high carbon footprint. Reducing emissions should be integral to plans for universal health coverage, say @FRasheed2 and colleagues https://t.co/wO90qRFvS5 @jeromebaddley @PoornimaPrabha3 @MartenRobert @WISHQatar
— The BMJ (@bmj_latest) November 14, 2021
#AHA21 – Estudo randomizado | Entre crianças e adolescentes submetidos a rastreamento ecocardiográfico e diagnosticados com doença cardíaca reumática latente, antibioticoprofilaxia secundária com penicilina G benzatina por 2 anos foi associada com redução da progressão ecocardiográfica (0,8 vs, 8,2% no grupo controle).
15 Nov, 2021 | 13:53hSecondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology
Comentários no Twitter
One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM
— Michael Marks (@dr_michaelmarks) November 13, 2021
Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC
— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021
Mortalidade global, regional e nacional entre jovens de 10 a 24 anos, 1950–2019: uma análise sistemática do Global Burden of Disease Study 2019.
15 Nov, 2021 | 13:43hComentários: Nearly two-thirds of those who died young in 2019 were male, research finds – The Guardian
Comentários no Twitter (fio – clique para saber mais)
✨🆕✨#GBDStudy 2019 analysis published by @TheLancet examined the global, regional, and national #mortality among young people aged 10-24 between 1950-2019, finding that mortality increased in 2019 with age globally🌎, particularly in males
Read here ⤵https://t.co/6gprq6gM0Z
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) October 29, 2021
OMS, CDC | Progresso global contra o sarampo fica ameaçado em meio à pandemia de COVID-19.
12 Nov, 2021 | 13:36hComunicado de imprensa: Global progress against measles threatened amidst COVID-19 pandemic – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
While reported #measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a 🆕 report from @CDCgov & WHO.
👉 https://t.co/EjRVRexcGd pic.twitter.com/KnBU5RZn5i
— World Health Organization (WHO) (@WHO) November 10, 2021
Consenso | Avanço na agenda de saúde pública global para doença hepática gordurosa não alcoólica.
11 Nov, 2021 | 16:15hConteúdos relacionados:
Non-alcoholic fatty liver disease: A patient guideline.
State of the art review: Management of non-alcoholic fatty liver disease
Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.
Comentário no Twitter
A Consensus Statement published in @NatRevGastroHep discusses recommendations for tackling the burden of non-alcoholic fatty liver disease. https://t.co/eX7Ht53DOB pic.twitter.com/lHKsfQmSj3
— Nature Portfolio (@NaturePortfolio) November 6, 2021
Estudo randomizado | Rastreamento universal no ensino médio pode ajudar a identificar e iniciar o tratamento de depressão em adolescentes.
11 Nov, 2021 | 16:00hComunicado de imprensa: School-based screening increases identification of, treatment for depression – Penn State
Comentários:
Comentários no Twitter
In a randomized clinical trial including 12,909 students at 14 Pennsylvania public high schools, adolescents randomized to receive a depression screen and identified with symptoms had 2.1 times higher odds of initiating depression treatment. https://t.co/b0l5ShCiHf pic.twitter.com/XptJDrH0Ne
— JAMA Network Open (@JAMANetworkOpen) November 8, 2021
Ações para transformar os métodos da USPSTF visando a mitigar o racismo sistêmico nos serviços médicos preventivos.
9 Nov, 2021 | 12:16hComentário: USPSTF Proposes Strategies to Mitigate Racism in Preventive Care – HealthDay
Revisão sistemática | Tratamento de pacientes de alta necessidade e alto custo.
9 Nov, 2021 | 12:12hVer também:
Conteúdos relacionados:
Systematic review of high-cost patients’ characteristics and healthcare utilization – BMJ Open
Multimorbidity: a priority for global health research – The Academy of Medical Sciences
The global burden of multiple chronic conditions: A narrative review – Preventive Medicine Reports
Redesigning Care for High-Cost, High-Risk Patients – Harvard Business Review
Multimorbidity: clinical assessment and management – NICE Guideline
Richard Smith: The challenge of high need, high cost patients – The BMJ Blogs
Better Care for People with Complex Needs – Institute for Healthcare Improvement